Skip to main content
HeartCited

Lycopene لـ Atherosclerosis

D الأبحاث توجد أبحاث أولية فحسب (دراسات مختبرية، تقارير حالات).

EURAMIC study showed association between adipose lycopene and lower MI risk. Cambridge study improved FMD in CAD patients. Interventional evidence is limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dlycopene\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

الخلاصة

EURAMIC study showed association between adipose lycopene and lower MI risk. Cambridge study improved FMD in CAD patients. Interventional evidence is limited.

Key Study Findings

Other
Functional food lycopene mitigates obesity-related cognitive decline via lipid metabolism regulation and neuroprotection via taurine …
Dose: 50 mg/kg lycopene in mice مقابل: HFD control mice Outcome: Cognitive function (Y-maze, MWM, novel object recognition) التأثير: None None

المجتمع المدروس: HFD-induced obese male C57BL/6 mice

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Observational Study n=60
Vascular Roads to a Healthier Brain: Lutein Moderates the Influence of Arterial Stiffness on Cognitive …
Dose: None مقابل: None Outcome: Carotenoid moderation of cfPWV-cognition relationship التأثير: Beta=0.53, p=0.04 for lutein moderation 0.02

المجتمع المدروس: Adults, mean age 38.6, 70% female

Meta-Analysis
Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
Dose: None مقابل: Placebo Outcome: Blood pressure التأثير: None None

المجتمع المدروس: None

systematic review n=90
A systematic review on the impact of nutrition and possible supplementation on the deficiency of …
Dose: None مقابل: Placebo التأثير: None None
Randomized Controlled Trial
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.
Dose: None مقابل: None Outcome: Cognitive decline التأثير: None None

المجتمع المدروس: Alzheimer's disease patients

Key Statistics

3

الدراسات

200

المشاركون

Positive

D

التقييم

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
6-15 mg/day
cardiovascularsupport:
15-30 mg/day

الحد الأعلى: Not formally established; up to 75 mg/day used in clinical trials

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
50 mg/kg lycopene in mice -- Positive --
None -- Positive --
None -- Positive 60
None -- Neutral --
None -- Negative 90
None -- Positive --
None -- Mixed --

أفضل وقت للتناول: With meals containing fat (cooking with olive oil enhances absorption 2-3x)

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Generally well-tolerated
  • Lycopenodermia (orange skin discoloration) at very high intake — harmless and reversible

التفاعلات المعروفة

  • Blood pressure medications (may have mild additive effect)
  • Beta-carotene (may compete for absorption)

الحد الأقصى المسموح به: Not formally established; up to 75 mg/day used in clinical trials

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Lycopene help with Atherosclerosis?
Based on 3 studies with 200 participants, there is preliminary evidence that needs more research that Lycopene may support Atherosclerosis management. Our evidence grade is D (Very Early Research).
How much Lycopene should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 6-15 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lycopene?
Reported side effects may include Generally well-tolerated, Lycopenodermia (orange skin discoloration) at very high intake — harmless and reversible. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lycopene and Atherosclerosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

References

  1. [1] Kazuhiko Nakadate et al.. Int J Mol Sci. 2025. Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications. doi:10.3390/ijms26115206 PubMed
  2. [2] Yuqing Wu et al.. Clin Nutr. 2025. Functional food lycopene mitigates obesity-related cognitive decline via lipid metabolism regulation and neuroprotection via taurine and glutathione pathway. doi:10.1016/j.clnu.2025.06.005 PubMed
  3. [3] Shreya Verma et al.. J Nutr. 2025. Vascular Roads to a Healthier Brain: Lutein Moderates the Influence of Arterial Stiffness on Cognitive Function. doi:10.1016/j.tjnut.2025.08.029 PubMed
  4. [4] Friederike Wylenzek et al.. Arch Gynecol Obstet. 2024. A systematic review on the impact of nutrition and possible supplementation on the deficiency of vitamin complexes, iron, omega-3-fatty acids, … doi:10.1007/s00404-024-07555-6 PubMed
  5. [5] Jolanta Flieger et al.. Int J Mol Sci. 2024. Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease. doi:10.3390/ijms25168982 PubMed
  6. [6] Sitong Wan et al.. Nutrients. 2024. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. doi:10.3390/nu16142213 PubMed
  7. [7] Michael A Grandner et al.. J Sleep Res. 2014. Sleep symptoms associated with intake of specific dietary nutrients. doi:10.1111/jsr.12084 PubMed
  8. [8] Graziano Riccioni. Curr Atheroscler Rep. 2009. Carotenoids and cardiovascular disease. doi:10.1007/s11883-009-0065-z PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.